Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Rising Tide Lifts Many Ships In Wake Of Eisai/Biogen’s Lecanemab Readout
Firms Boosted Regardless Of Alzheimer’s Drugs’ Mechanisms
Sep 28 2022
•
By
Mandy Jackson
Lilly and Roche, neck-and-neck with Eisai and Biogen, also rose on the Clarity AD data • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D